SuperworthInnovative Eyewear EPS LUCY
Diluted earnings per share by quarter and over the last twelve months, from 2022.
- Last 12 months, to Jun 30, 2026
- −$1.36
- Latest quarter, Q2 FY26
- −$0.26
- Fiscal year 2025
- −$2.11
Innovative Eyewear's earnings per share was −$1.36 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was −$0.26.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$2.11 | n/a |
| FY2024 | −$6.32 | n/a |
| FY2023 | −$11.91 | n/a |
| FY2022 | −$17.40 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$0.26 | n/a | −$1.36 | |
| Q1 FY26 | −$0.37 | n/a | −$1.76 | |
| Q4 FY25 | −$0.35 | n/a | −$2.11 | |
| Q3 FY25 | −$0.38 | n/a | −$2.63 | |
| Q2 FY25 | −$0.66 | n/a | −$3.24 | |
| Q1 FY25 | −$0.72 | n/a | −$4.45 | |
| Q4 FY24 | −$0.87 | n/a | −$6.32 | |
| Q3 FY24 | −$0.99 | n/a | −$8.92 | |
| Q2 FY24 | −$1.87 | n/a | −$10.01 | |
| Q1 FY24 | −$2.59 | n/a | −$10.70 | |
| Q4 FY23 | −$3.47 | n/a | −$11.91 | |
| Q3 FY23 | −$2.08 | n/a | −$13.64 |
Against its peers
Companies in Healthcare nearest Innovative Eyewear's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| LUCYInnovative Eyewear | −$1.36 | |
| NEPHNephros | $0.16 | +33% a year |
| ATNMActinium Pharmaceuticals | $0.36 | |
| APTAlpha Pro Tech | $0.41 | +24% a year |
| SPROSpero Therapeutics | $0.11 | |
| LFVNLifevantage | $0.40 | −46% a year |
| Peer median | $0.36 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Innovative Eyewear
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.